| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Dec 3, 2025 | PTC THERAPEUTICS, INC. | CEO | Sell | 90.0 | +12,197 | 3.61% | ✗ | $271.1K |
| Aug 1, 2025 | Aug 5, 2025 | PTC THERAPEUTICS, INC. | CEO | Sell | 97.5 | +64,261 | 23.50% | ✗ | $555.6K |
| Apr 22, 2025 | Apr 24, 2025 | PTC THERAPEUTICS, INC. | CEO | Sell | 42.5 | -2,804 | -1.02% | ✗ | $136.7K |
| Feb 19, 2025 | Feb 21, 2025 | PTC THERAPEUTICS, INC. | CEO | Sell | 40.0 | -7,792 | -2.75% | ✗ | $390.5K |
| Jan 7, 2025 | Jan 10, 2025 | PTC THERAPEUTICS, INC. | CEO | Sell | 42.5 | -4,544 | -1.58% | ✗ | $204K |
| Dec 31, 2024 | Jan 3, 2025 | PTC THERAPEUTICS, INC. | CEO | Sell | 40.0 | -8,279 | -3.67% | ✗ | $373.9K |
| Apr 19, 2024 | Apr 22, 2024 | PTC THERAPEUTICS, INC. | CEO | Sell | 42.5 | -3,361 | -1.47% | ✗ | $83.7K |
| Apr 17, 2024 | Apr 19, 2024 | PTC THERAPEUTICS, INC. | CEO | Sell | 48.8 | -1,307 | -0.57% | ✗ | $32.9K |
| Jan 8, 2024 | Jan 10, 2024 | PTC THERAPEUTICS, INC. | CEO | Sell | 42.5 | -7,680 | -4.57% | ✗ | $222K |
| Jan 5, 2024 | Jan 9, 2024 | PTC THERAPEUTICS, INC. | CEO | Sell | 40.0 | -10,107 | -5.67% | ✗ | $274.4K |
| Apr 18, 2023 | Apr 20, 2023 | PTC THERAPEUTICS, INC. | CEO | Sell | 95.0 | +24,789 | 31.84% | ✗ | $63K |
| Jan 10, 2023 | Jan 12, 2023 | PTC THERAPEUTICS, INC. | COO | Sell | 42.5 | -4,517 | -5.48% | ✗ | $197.1K |
| Jan 9, 2023 | Jan 11, 2023 | PTC THERAPEUTICS, INC. | COO | Sell | 48.8 | -731 | -0.88% | ✗ | $30.5K |
| Apr 19, 2022 | Apr 21, 2022 | PTC THERAPEUTICS, INC. | COO | Sell | 46.3 | -897 | -1.56% | ✗ | $38.1K |
| Jan 7, 2022 | Jan 11, 2022 | PTC THERAPEUTICS, INC. | COO | Sell | 91.3 | +40,225 | 233.38% | ✗ | $29.9K |
| Apr 19, 2021 | Apr 21, 2021 | PTC THERAPEUTICS, INC. | Chief Development Officer | Sell | 25.0 | -2,500 | -12.95% | ✓ | $118.1K |
| Jan 15, 2021 | Jan 20, 2021 | PTC THERAPEUTICS, INC. | Chief Development Officer | Sell | 17.5 | -4,300 | -18.21% | ✓ | $297.1K |
| Jan 8, 2021 | Jan 12, 2021 | PTC THERAPEUTICS, INC. | Chief Development Officer | Sell | 12.5 | -5,500 | -22.17% | ✓ | $383.4K |
| Jan 6, 2021 | Jan 8, 2021 | PTC THERAPEUTICS, INC. | Chief Development Officer | Sell | 97.5 | +5,114 | 15.26% | ✓ | $268.1K |